Global Therapeutic Drug Monitoring Market to Reach $3.72 Billion by 2029, Growing at 11% CAGR

What industry-specific factors are fueling the growth of the therapeutic drug monitoring market?
The therapeutic drug monitoring market's growth is anticipated to be fueled by an increase in organ transplant operations. The transplant of an organ from a donor to a recipient is what organ transplantation entails. For patient management after solid organ transplantation, therapeutic drug monitoring (TDM) of immunosuppressive drugs is considered an efficient strategy. By enhancing TDM, one can prevent the consequences of both toxic and unacceptably low dosage therapies, such as the rejection of the transplanted organ. As published in a USA-based United Network for Organ Sharing article in January 2023, there were 42,887 organ transplants performed in the US in 2022, reflecting a 3.7% increase from 2021. Thus, the escalating number of organ transplants is propelling the therapeutic drug monitoring market.

Get Your Therapeutic Drug Monitoring Market Report Here:
https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report

What Is the projected market size and growth rate for the therapeutic drug monitoring market?
In recent years, there has been a significant expansion in the scale of the therapeutic drug monitoring market. It's projected to escalate from $2.23 billion in 2024 to $2.43 billion in 2025, experiencing a Compound Annual Growth Rate (CAGR) of 8.9%. The growth observed in the historical period can be linked to surging occurrences of chronic ailments, concerns regarding drug safety, the incorporation of pharmacogenomics, advancements in drug development, and the regulatory focus on precision medicine.

The market for therapeutic drug monitoring is projected to experience accelerated expansion in the coming years, with an estimated worth of $3.72 billion in 2029, representing a compound annual growth rate (CAGR) of 11.3%. This growth during the forecast period is attributed to increasing applications in the field of oncology, rising adoption of personalized medicine, growing elderly population worldwide, expanding point-of-care testing, and increased investment in pharmaceutical research and development. Key trends anticipated during this projected period encompass the rise of personalized medicine, technological innovation, growing drug creation and use, the proliferation of point-of-care testing (POCT), as well as emerging biomarkers and assay technologies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10069&type=smp

What new trends are reshaping the therapeutic drug monitoring market and its opportunities?
Leading firms in the therapeutic drug monitoring market are prioritizing the advancement of anti-idiotypic antibody technology to boost the precision and specificity of assays for the correct computation of biologic drug levels and evaluation of patient immune reactions. The said technology is beneficial in therapeutic drug monitoring as it allows an exact detection and quantification of biologic drug levels, guarantees exact dosage, and monitors patient immune responses. For example, in June 2024, Bio-Rad Laboratories, a biotechnology corporation situated in the US, introduced new anti-idiotypic and anti-monomethyl auristatin E (MMAE) antibodies for bioanalytical assays, bolstering pharmacokinetic (PK) and antidrug-antibody (ADA) supervision. These ground-breaking antibodies amplify the dependability of assays for antibody-drug conjugates (ADCs), vital for the therapeutic drug monitoring market, allowing meticulous assessments of drug levels and immune responses for the best patient dosage.

What major market segments define the scope and growth of the therapeutic drug monitoring market?
The therapeutic drug monitoring market covered in this report is segmented -

1) By Product: Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors
2) By Technology: Immunoassays, Chemiluminescence Immunoassays, Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, Radioimmunoassay, Other Immunoassays, Chromatography-Ms, Lc-Ms, Gc-Ms
3) By Class Of Drug: Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs
4) By End-user: Hospital Laboratories, Commercial and Private Laboratories, Other End Users

Subsegments:
1) By Consumables: Reagents, Test Kits, Sample Collection Containers, Calibration Standards
2) By Equipment: Analyzers, Incubators, Centrifuges, Other Equipment
3) By Immunoassay Analyzers: ELISA Analyzers, Chemiluminescent Immunoassay Analyzers, Radioimmunoassay Analyzers
4) By Chromatography And Detectors: High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Mass Spectrometry (MS), Other Chromatography Techniques

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10069

Which region dominates the therapeutic drug monitoring market?
North America was the largest region in the therapeutic drug monitoring market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global therapeutic drug monitoring market report during the forecast period. The regions covered in the therapeutic drug monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the therapeutic drug monitoring industry growth?
Major companies operating in the therapeutic drug monitoring market include Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Sekisui Medical Co., Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Randox Laboratories Limited, Chromsystems Instruments & Chemicals GmbH, Grifols SA, Merck KGaA, BioChem Pharmaceuticals, Beckman Coulter Inc., DiaSorin S.p.A., Hologic Inc., Immunodiagnostic Systems Holdings plc, Kronus Inc., QuidelOrtho Corporation, Sysmex Corporation, TDM Solutions Inc., Theradiag, Tosoh Bioscience LLC, Trinity Biotech plc, Associated Regional and University Pathologists Inc., Mayo Clinic Laboratories, Quest Diagnostics

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10069&type=smp

What Is Covered In The Therapeutic Drug Monitoring Global Market Report?

• Market Size Forecast: Examine the therapeutic drug monitoring market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the therapeutic drug monitoring market for a structured understanding.
• Key Players Overview: Analyze major players in the therapeutic drug monitoring market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the therapeutic drug monitoring market.
• Segment Contributions: Evaluate how different segments drive overall growth in the therapeutic drug monitoring market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the therapeutic drug monitoring market.
• Industry Challenges: Identify potential risks and obstacles affecting the therapeutic drug monitoring market.
• Competitive Landscape: Review strategic developments in the therapeutic drug monitoring market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.